Agios Pharmaceuticals | AGIO - Gross Profit On Sales



Agios Pharmaceuticals reported $10.75M in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
AbbVie USD 9.34B 1.36B Mar/2025
Agios Pharmaceuticals USD 10.75M 3.11M Jun/2025
Alnylam Pharmaceuticals USD 630.74M 107.59M Jun/2025
Amgen USD 6.17B 624M Jun/2025
Arrowhead Research 27.77M 514.94M Jun/2025
Astellas Pharma JPY 410.96B 28.53B Jun/2025
AstraZeneca USD 11.98B 637M Jun/2025
Bayer EUR 6.38B 1.74B Jun/2025
Biogen USD 2.04B 238.8M Jun/2025
BioMarin Pharmaceutical USD 670.47M 76.89M Jun/2025
Bristol-Myers Squibb USD 8.9B 714M Jun/2025
Daiichi Sankyo JPY 382.25B 42.1B Jun/2025
Eli Lilly USD 13.11B 2.61B Jun/2025
Exelixis USD 548.79M 12.52M Jun/2025
Gilead Sciences USD 5.58B 453M Jun/2025
GlaxoSmithKline GBP 5.82B 229M Jun/2025
Incyte USD 1.14B 151.67M Jun/2025
Ionis Pharmaceuticals USD 448M 317.85M Jun/2025
Merck USD 12.99B 224M Jun/2025
Moderna USD 18M 1000K Jun/2025
Novartis USD 11.51B 1.12B Jun/2025
Novartis USD 11.52B 1.27B Jun/2025
Pfizer USD 10.88B 248M Jun/2025
Regeneron Pharmaceuticals USD 3.15B 581M Jun/2025
Roche Holding CHF 11.69B 48M Dec/2024
Sarepta Therapeutics USD 457.87M 149.43M Jun/2025
Vertex Pharmaceuticals USD 2.56B 150M Jun/2025